Prelude Capital Management’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-200
Closed -$6K – 2202
2020
Q2
$6K Sell
200
-100
-33% -$3.32K ﹤0.01% 1683
2020
Q1
$8K Sell
300
-1,200
-80% -$46.4K ﹤0.01% 1167
2019
Q4
$69K Buy
+1,500
New +$70.5K ﹤0.01% 1231
2019
Q2
– Sell
-807
Closed -$46K – 2018
2019
Q1
$46K Sell
807
-100
-11% -$5.61K ﹤0.01% 1144
2018
Q4
$48K Buy
907
+775
+587% +$44.1K ﹤0.01% 1122
2018
Q3
$8K Sell
132
-533
-80% -$29.9K ﹤0.01% 1537
2018
Q2
$38K Buy
665
+465
+233% +$26.5K ﹤0.01% 1192
2018
Q1
$12K Hold
200
– – ﹤0.01% 1338
2017
Q4
$11K Sell
200
-2,400
-92% -$124K ﹤0.01% 1198
2017
Q3
$123K Buy
+2,600
New +$122K 0.01% 819
2017
Q1
– Sell
-9,460
Closed -$342K – 1700
2016
Q4
$342K Buy
9,460
+3,660
+63% +$139K 0.04% 398
2016
Q3
$248K Buy
5,800
+1,100
+23% +$49.1K 0.03% 499
2016
Q2
$199K Buy
4,700
+300
+7% +$13K 0.03% 496
2016
Q1
$183K Sell
4,400
-800
-15% -$31.4K 0.03% 583
2015
Q4
$204K Hold
5,200
– – 0.03% 565
2015
Q3
$176K Hold
5,200
– – 0.03% 647
2015
Q2
$172K Buy
+5,200
New +$179K 0.02% 686
2014
Q4
– Sell
-4,600
Closed -$142K – 2086
2014
Q3
$142K Buy
4,600
+500
+12% +$16.6K 0.02% 880
2014
Q2
$149K Buy
+4,100
New +$133K 0.02% 866

Other funds holding OFIX

Prelude Capital Management's OFIX Position: Q3 2020 in Review

Prelude Capital Management sold out of Orthofix Medical (OFIX) in Q3 2020, closing a stake of 200 shares — an estimated $6K sold.

Prelude Capital Management first reported a position in OFIX in Q2 2014 and held it in 19 quarters. The position peaked at $342K in Q4 2016. 134 funds tracked by Wall St. Rank hold OFIX as of Q3 2020.

  • Prelude Capital Management reported no remaining Orthofix Medical position as of Q3 2020 after selling out during the quarter.
  • Prelude Capital Management sold 200 Orthofix Medical shares in Q3 2020, an estimated $6K.
  • Prelude Capital Management first reported a position in Orthofix Medical in Q2 2014 and held it in 19 quarters.
  • Prelude Capital Management's Orthofix Medical position peaked at $342K in Q4 2016.
  • 134 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2020.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.